Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change
26-07-02	€0.6330	+7.65%
26-07-01	€0.5880	-1.18%
26-06-30	€0.5950	0.00%
26-06-29	€0.5950	-4.19%
26-06-26	€0.6210	+0.16%

Delayed Quote Deutsche Boerse AG

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Delayed Deutsche Boerse AG Other stock markets 02:01:23 2026-07-02 EDT			5-day change	1st Jan Change
0.6330 ^EUR	+7.65%		+2.10%	-

06-19	Claude Lenoir appointed interim chairman of Theraclion
06-19	Theraclion Chairman Steps Down; Interim Successor Named	MT

Market Cap	49.2M 56.04M 45.29M 42.2M 79.59M 5.33B 81.21M 545M 211M 2.62B 210M 206M 9.1B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	57.05M 64.98M 52.52M 48.94M 92.29M 6.18B 94.17M 632M 245M 3.03B 244M 239M 10.55B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.37%	Yield 2024 *	-	Yield 2025	-

06-19	Claude Lenoir appointed interim chairman of Theraclion
06-19	Theraclion Chairman Steps Down; Interim Successor Named	MT
06-18	Theraclion Announces Board Changes	CI
06-08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
06-05	Theraclion deploys first Sonovein system in China
06-05	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
06-04	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
06-04	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
06-01	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
05-11	Bouygues, Euronext, Vallourec... stocks to watch today in Paris
05-11	Theraclion raises nearly 6 million euros via units with warrants
04-20	France's Theraclion Targets EUR6 Million via Capital Increase	MT
04-20	Casino, Rubis, Sanofi... stocks to watch today in Paris

06-18	Theraclion Announces the Evolution of Its Board of Directors	BU
06-08	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU
06-04	Theraclion Announces First Clinical Deployment of Sonovein® in Hainan, China	BU
06-01	Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein® SpeedPulse Were Presented	BU
05-11	Theraclion : Inside Information / Other news releases	PU

Theraclion Stock Deutsche Boerse AG

Stocks

941

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Course Extremes

Managers and Directors: Theraclion

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

06-19	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer
06-19	Les puces américaines en weekend prolongé
06-19	Claude Lenoir nommé président par intérim de Theraclion
06-18	THERACLION ANNONCE L’ÉVOLUTION DE SON CONSEIL D'ADMINISTRATION
06-13	Agenda des dividendes et des AG France : GTT, Alten et Exail sur les tablettes

1 week	0.59	0.63
1 month	0.59	0.93
Current year	0.44	0.93
1 year	0.44	0.93
3 years	0.44	0.93
5 years	0.44	0.93
10 years	0.44	0.93

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	2023-05-23
Julie Veisseire DFI	Director of Finance/CFO	-	-
Gaylord Tallec COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Renaud Saleur BRD	Director/Board Member	-	2018-01-31
Ari Kellen BRD	Director/Board Member	-	2019-02-12
Shawn Langer BRD	Director/Board Member	-	2019-02-12

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	+7.65%	+2.10%	-	-	56.04M
THERMO FISHER SCIENTIFIC, INC.	+2.39%	+4.29%	+21.80%	-1.61%	191B
INTUITIVE SURGICAL, INC.	+1.18%	+0.14%	-25.21%	+17.68%	143B
DANAHER CORPORATION	+1.70%	+2.57%	-3.67%	-19.28%	137B
BOSTON SCIENTIFIC CORPORATION	+0.89%	-3.15%	-58.90%	-20.39%	64B
EDWARDS LIFESCIENCES CORPORATION	+1.69%	+2.60%	+19.19%	-2.48%	52.97B
SIEMENS HEALTHINEERS AG	-0.71%	-0.47%	-27.79%	-32.44%	43.82B
AGILENT TECHNOLOGIES, INC.	+0.42%	+1.34%	+10.74%	+10.93%	37.67B
WATERS CORPORATION	+0.82%	+2.42%	+5.91%	+41.87%	37.13B
GE HEALTHCARE TECHNOLOGIES INC.	+1.33%	-0.03%	-14.60%	-20.16%	29.5B
Average	+1.65%	+2.37%	-8.06%	-2.88%	81.72B
Weighted average by Cap.	+1.29%	+3.37%	-5.05%	-2.61%

	2024	2025
Net sales	830K 946K 764K 712K 1.34M 89.9M 1.37M 9.19M 3.56M 44.13M 3.55M 3.47M 154M	652K 743K 600K 559K 1.05M 70.6M 1.08M 7.22M 2.8M 34.65M 2.79M 2.73M 121M
Net income	-5.76M -6.56M -5.3M -4.94M -9.31M -623M -9.5M -63.74M -24.69M -306M -24.62M -24.09M -1.06B	-5.69M -6.48M -5.24M -4.88M -9.2M -616M -9.39M -62.99M -24.41M -302M -24.33M -23.81M -1.05B
Net Debt	3.41M 3.88M 3.14M 2.93M 5.52M 369M 5.63M 37.76M 14.63M 181M 14.59M 14.27M 631M	7.85M 8.94M 7.23M 6.73M 12.7M 850M 12.96M 86.93M 33.68M 417M 33.58M 32.85M 1.45B